secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2025-09-24T23:59:59+00:00
Accession:  0001213900-25-091109
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics elects Steven Zelenkofske as director; ratifies auditor
-----------------------------------------------------------------------------

- At 2025 annual meeting, stockholders elected Steven Zelenkofske as Class III director with 669,494 votes for, 15,099 withheld.
- Ratification of WithumSmith+Brown as FY2025 auditor passed with 1,207,152 votes for, 64,913 against, 12,681 abstain.
- Broker non-votes of 600,153 on director election; none on auditor ratification (routine matter).
- Meeting held September 24, 2025; quorum of 1,284,746 shares out of 2,046,854 outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025091109/0001213900-25-091109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025091109/ea0258629-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-091109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer